Business

CDC panel skeptical of fourth Covid shots for broader population, says U.S. needs clear vaccine strategy


Registered nurse Orlyn Grace (R) administers the COVID-19 booster vaccination to Diane Cowdrey (L) at a COVID-19 vaccination clinic on April 6, 2022 in San Rafael, California.

Justin Sullivan | beautiful pictures

The CDC’s panel of independent vaccine experts has signaled that it is not ready to endorse a fourth Covid shot to the general population until the agency adopts a clear strategy.

Team, in a five-hour meeting on Wednesday, Most agree that the continued deployment of boosters to prevent infection is not a realistic goal with the current generation of vaccinations.

The CDC’s Advisory Committee on Immunization Practices discussed the United States’ vaccination strategy in light of the expected wave of infections. This is the first meeting of the committee since CDC removed fourth dose of Pfizer or Moderna for people 50 years of age and older at the end of March, as well as a fifth dose for people 12 years of age and older with weakened immune systems.

Dr Sarah Long, a member of the committee, said public health authorities need to abandon the idea that vaccines can prevent Covid infections. Instead, she said, they should let the public know that the primary goal is to prevent serious illness, hospitalizations and deaths.

Chasing the rainbow

Long, professor of paediatrics at Drexel University, said: “With vaccines currently available, we should not chase the hope that those vaccines can prevent infection, transmission and even even mild illness because we knew it was impossible.” of Medicine. “We just have to give up on that with these vaccines and focus on preventing severe illness and preventing death.”

Long criticized the CDC for giving up a fourth shot for older adults without consulting the committee, saying the decision created public confusion and could lead to additional fatigue. She said having a full public discussion within the committee about vaccine recommendations would help restore public trust.

Pfizer and Moderna’s vaccines have proven highly effective in preventing Covid hospitalizations, but their ability to protect against infections and mild illness rapidly declines over time, a challenge exacerbated by rapid growth of the virus. Vaccine manufacturers have developed injections to target the mutant protein of the virus that emerged in Wuhan, China in 2019. The virus uses the virus to invade human cells. and since that protein has mutated in the last two years, it has become more difficult for vaccines to prevent infection.

CNBC Health & Science

Read CNBC’s latest news on the Covid pandemic:

65% effective for mild disease

Data presented by CDC officials Wednesday showed that three injections of Pfizer or Moderna were 79 percent effective in preventing hospitalization and 94 percent effective in preventing serious illness or death among adults. healthy immune system during the unprecedented winter omicron infection. Three doses are about 65% effective in preventing mild illness.

Dr. Beth Bell, Director of the National Center for Emerging and Infectious Diseases of Animals, says asking people to get vaccinated every four to six months is not a sustainable public health strategy. Such an approach, she said, could undermine confidence in the vaccination campaign. Bell says a two-shot and one booster series of primary vaccines provide adequate protection now for people with healthy immune systems.

“I’m just very worried about us meeting and looking at additional doses to get smaller and smaller margins and create the impression that we I do not have an effective vaccination program. of Public Health.

Dr. David Kimberlin of the American Academy of Pediatrics said the CDC should adopt a more enduring immunization strategy now to avoid having to respond to the next crisis. The CDC should make it clear that most Americans will initially need three doses and will then need a booster shot once a year to maintain protection from serious illness, Kimberlin said.

Concerns of Long Covid

However, committee chair Dr. Grace Lee said the United States needed to invest in developing vaccines that are effective at preventing infection, pointing out that even mild infections can cause serious illness. can lead to prolonged spasticity with potential health consequences.

“If we focus on hospitalizations and deaths in acute illness, you don’t think about the long-term consequences of Covid, and that can happen,” said Lee, professor of pediatrics at Stanford University. even in people with mild symptoms. Medicine. Lee said being out of school or missing school due to infection is a big challenge, especially for communities that don’t always have easy access to health care.

While three doses may be enough for healthy adults, people with compromised immune systems are still vulnerable to severe illness, according to Dr. Camille Kotton, an infectious disease specialist at Massachusetts General Hospital. They are at risk of infection even with adequate vaccination, booster treatment and monoclonal antibody prevention, Kotton said.

“In a sense, they are the ones who are being left out somewhat in the pandemic,” said Kotton. “I just ask that we maintain a substantial focus on immunocompromised patients,” she said.

FDA meeting

The CDC committee meeting took place after Food and Drug Administration independent advisors met earlier this month to develop a new vaccine selection framework that targets the mutations the virus has evolved over the course of a pandemic. Public health authorities expect another wave of infections this fall and fear that a new variant could emerge that undermines existing vaccines.

Dr. Peter Marks, the head of the FDA department responsible for the safety and effectiveness of vaccines, told the drug regulator’s advisory committee that the United States has a deadline of up to May at the latest. 6 to select a new vaccine formulation to be ready for fall. Marks said waning immunity from the vaccine could leave the US vulnerable to another spike as people move inside during the colder months. FDA committee members also cast doubt on the requirement that the broader population continue to increase until there are clear data demonstrating that it is necessary to prevent serious illness.

“I think we’re working very hard and with the idea that we simply can’t motivate people as often as we are now,” Marks told the committee. “I am the first to admit that this authorized fourth booster is a containment measure until we are all set for the next potential booster based on data,” said Marks. whether emerging.



Source link

newsofmax

News of max: Update the world's latest breaking news online of the day, breaking news, politics, society today, international mainstream news .Updated news 24/7: Entertainment, Sports...at the World everyday world. Hot news, images, video clips that are updated quickly and reliably

Related Articles

Back to top button
Immediate Matrix Immediate Maximum
rumi hentai besthentai.org la blue girl 2 bf ganda koreanporntrends.com telugusareesex hakudaku mesuhomo white day flamehentai.com hentai monster musume سكس محارم الماني pornotane.net ينيك ابنته tamil movie downloads tubeblackporn.com bhojpuri bulu film
sex girel pornoko.net redtube mms odia sex mobi tubedesiporn.com nude desi men صور سكسي متحركه porno-izlemek.net تردد قنوات سكس نايل سات sushmita sex video anybunny.pro bengali xxx vido desigay tumblr indianpornsluts.com pakistani escorts
desi aunty x videos kamporn.mobi hot smooch andaaz film video pornstarsporn.info tamil sexy boobs internet cafe hot tubetria.mobi anushka sex video desi sexy xnxx vegasmovs.info haryana bf video 黒ギャル 巨乳 無修正 javvideos.net 如月有紀